Watch and Wait and Surgical Treatment for Clinical Complete Responders After Non-Curative Therapy for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
TACE Combined With Penpulimab and Anlotinib for Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy
- Status
- TERMINATED
- Phase
- N/A
IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation
- Status
- UNKNOWN
- Phase
- NA
Autologous HBV-specific T Cell Receptor Engineered T Cells (TCR-T) in Patients With HBV-related Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE1
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC
- Status
- COMPLETED
- Phase
- N/A
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC
- Status
- COMPLETED
- Phase
- N/A
Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors
- Status
- RECRUITING
- Phase
- PHASE4
Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Durvalumab Plus Lenvatinib as First-line Treatment for Unresectable Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Postoperative Adjuvant Therapy of HCC Based on PD-1
- Status
- COMPLETED
- Phase
- N/A
Multi-Detector CT Angiography With 3D Reconstruction Versus Digital Subtraction Angiography
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Liver Cancer Disparities in American Indian and Alaska Native Persons
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Impact of Hepatitis B Immunoglobulins in Patients With Chronic Hepatitis B on Hepatocellular Carcinoma - a Proof of Concept Study
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer
- Status
- WITHDRAWN
- Phase
- N/A